EVH
Evolent Health, Inc.
$4.66
+10.43%
$524.2M
No data for this timeframe.
Vol
Market Cap$524.2M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (85%)
Inst. Holders9 funds
Inst. Value$88.8M
Inst. Activity3 buys / 3 sells
SEC Reports2
Recent Activity
Jun 4, 2026
Insider
Ajayi Toyin sold 41,096 shares
Director @ $0.00 ($0.00)
Jun 4, 2026
Insider
GUERTIN SHAWN M sold 41,096 shares
Director @ $0.00 ($0.00)
Jun 4, 2026
Insider
GRUA PETER J sold 41,096 shares
Director @ $0.00 ($0.00)
Jun 3, 2026
short_volume
Short Volume: EVH — 63.0% short (0.9M / 1.4M)
Short: 879,032 | Exempt: 311 | TRF Vol: 1,395,393 | Short Ratio: 63.0% | Off-exchange volume (dark p
Apr 24, 2026
SEC
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for J
DEFA14A — Impact 2/10
Feb 24, 2026
SEC
Evolent Health reported a significant year-over-year decline in revenue and net loss for 2025, driven by goodwill and ot
8-K — Impact 6/10
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
1,537,524 shares ($6.2M)
Inst.
BANK OF AMERICA CORP — TRIM
560,950 shares ($2.2M)
Price Targets
$5.75
+21.8% upside
Strong Buy
Current $4.72
Low $3.00
Median $6.00
High $8.00
14 analysts
$3.00
$8.00
Analyst Ratings
6Strong Buy
11Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 15, 2026 | Citigroup | MAINTAIN | Buy → Buy |
| May 12, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 7, 2026 | Needham | MAINTAIN | Buy → Buy |
| Mar 2, 2026 | Oppenheimer | MAINTAIN | Outperform → Outperform |
| Feb 26, 2026 | Citigroup | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.02 ▼ -12.4% | $-0.07 — $0.01 | 82% YoY | 11 |
| Next Q | $0.05 ▼ -27.0% | $0.00 — $0.09 | 5% YoY | 12 |
| Current FY | $0.20 ▲ +14.4% | $0.13 — $0.26 | 118% YoY | 9 |
| Next FY | $0.40 ▼ -8.6% | $0.16 — $0.71 | 106% YoY | 12 |
Latest Reports
NEUTRAL
DEFA14A
2/10
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for J
Apr 24, 2026
MIXED
8-K
6/10
Evolent Health reported a significant year-over-year decline in revenue and net loss for 2025, driven by goodwill and ot
Feb 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $37.1M | ADD |
| VANGUARD GROUP INC | $35.7M | — |
| TWO SIGMA INVESTMENTS, LP | $6.2M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $6.1M | NEW |
| BANK OF AMERICA CORP | $2.2M | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Ajayi Toyin | A | $0.00 |
| Jun 4, 2026 | GUERTIN SHAWN | A | $0.00 |
| Jun 4, 2026 | GRUA PETER | A | $0.00 |
| Jun 4, 2026 | Glass Russell | A | $0.00 |
| Jun 4, 2026 | Jelinek Richard | A | $0.00 |
9 institutional holders with $88.8M total value (22,195,524 shares) as of 2025-Q4. Top holders: MORGAN, VANGUARD, TWO.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 9,278,123 | $37.1M | 41.8% | ADD +68.4% |
| 2 | VANGUARD GROUP INC | 8,914,065 | $35.7M | 40.2% | — |
| 3 | TWO SIGMA INVESTMENTS, LP | 1,537,524 | $6.2M | 6.9% | ADD +80.6% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,516,215 | $6.1M | 6.8% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 560,950 | $2.2M | 2.5% | TRIM -41.7% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 174,599 | $698.4K | 0.8% | TRIM -43.7% |
| 7 | WELLS FARGO & COMPANY/MN | 136,524 | $546.1K | 0.6% | ADD +46.9% |
| 8 | NORGES BANK | 63,454 | $253.8K | 0.3% | NEW |
| 9 | FMR LLC | 14,070 | $56.3K | 0.1% | NEAR_EXIT -99.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | ADD | 851,138 | 1,537,524 | +80.6% | $6.2M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 961,797 | 560,950 | -41.7% | $2.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 310,099 | 174,599 | -43.7% | $698.4K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 92,941 | 136,524 | +46.9% | $546.1K | 2025-Q4 |
| NORGES BANK | NEW | — | 63,454 | — | $253.8K | 2025-Q4 |
| FMR LLC | NEAR_EXIT | 8,749,996 | 14,070 | -99.8% | $56.3K | 2025-Q4 |
| FMR LLC | ADD | 6,420,384 | 8,749,996 | +36.3% | $74.0M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 364,112 | 851,138 | +133.8% | $7.2M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 310,099 | — | $2.6M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 399,394 | 92,941 | -76.7% | $786.3K | 2025-Q3 |
| NORGES BANK | EXIT | 179,062 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | ADD | 4,780,688 | 8,052,587 | +68.4% | $90.7M | 2025-Q2 |
| FMR LLC | DOUBLED | 3,206,133 | 6,420,384 | +100.3% | $72.3M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 574,597 | 1,058,797 | +84.3% | $11.9M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 66,726 | 399,394 | +498.6% | $4.5M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 545,883 | 364,112 | -33.3% | $4.1M | 2025-Q2 |
| NORGES BANK | NEW | — | 179,062 | — | $2.0M | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 570,368 | 4,780,688 | +738.2% | $45.3M | 2025-Q1 |
| FMR LLC | TRIM | 4,476,482 | 3,206,133 | -28.4% | $30.4M | 2025-Q1 |
| UBS Group AG | ADD | 1,817,467 | 2,542,214 | +39.9% | $24.1M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 545,883 | — | $5.2M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 775,420 | 301,248 | -61.2% | $2.9M | 2025-Q1 |
| NORGES BANK | EXIT | 1,112,834 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 179,125 | 1,817,467 | +914.6% | $20.4M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 522,771 | 775,420 | +48.3% | $8.7M | 2024-Q4 |
10 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Ajayi Toyin | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | GUERTIN SHAWN M | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | GRUA PETER J | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | Glass Russell Monroe | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | Jelinek Richard M | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | KECK KIM | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | Springstubb Brendan B | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | Smith Jill D. | Director | A | 41,096 | $0.00 | $0.00 |
| Jun 4, 2026 | Barbarosh Craig A. | Director | A | 41,096 | $0.00 | $0.00 |
| Mar 3, 2026 | McCarthy Daniel Joseph | PRESIDENT | F | 24,027 | $3.51 | $84.3K |
| Mar 2, 2026 | McCarthy Daniel Joseph | PRESIDENT | A | 39,281 | $0.00 | $0.00 |
| Mar 2, 2026 | McCarthy Daniel Joseph | PRESIDENT | A | 826,440 | $0.00 | $0.00 |
| Mar 1, 2026 | McCarthy Daniel Joseph | PRESIDENT | F | 7,811 | $3.25 | $25.4K |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (85% buy). Based on 20 analysts: 6 strong buy, 11 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$5.75 mean target
+21.8% upside
Strong Buy (3.00)
$3.00 Low
$8.00 High
| Metric | Value |
|---|---|
| Current Price | $4.72 |
| Target Low | $3.00 |
| Target Mean | $5.75 |
| Target Median | $6.00 |
| Target High | $8.00 |
| # Analysts | 14 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.02 | $-0.07 | $0.01 | 81.8% | -12.4% | 3↑ 2↓ | $0.6B | 34.8% | 11 |
| Next Q 2026-09-30 |
$0.05 | $0.00 | $0.09 | 5.0% | -27.0% | 2↑ 5↓ | $0.7B | 41.8% | 12 |
| Current FY 2026-12-31 |
$0.20 | $0.13 | $0.26 | 118.1% | +14.4% | 3↑ 2↓ | $2.5B | 32.9% | 9 |
| Next FY 2027-12-31 |
$0.40 | $0.16 | $0.71 | 105.7% | -8.6% | 2↑ 8↓ | $2.9B | 17.7% | 12 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.018 | |
| 7d ago | $-0.009 | -0.010 |
| 30d ago | $-0.016 | -0.002 |
| 60d ago | $-0.016 | -0.002 |
| 90d ago | $0.058 | -0.076 |
10 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 15, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| May 12, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 7, 2026 | Needham | MAINTAIN | Buy | Buy |
| Mar 2, 2026 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Feb 26, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | UBS | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 25, 2026 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Feb 25, 2026 | Keybanc | DOWNGRADE | Overweight | Sector Weight |
| Feb 25, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 2, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 9, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Jan 6, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| May 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Apr 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Mar 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Feb 1, 2026 | 6 | 12 | 2 | 0 | 0 | 90% | |
| Jan 1, 2026 | 6 | 12 | 1 | 0 | 0 | 95% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 3, 2026
short_volume
Short Volume: EVH — 63.0% short (0.9M / 1.4M)
Short: 879,032 | Exempt: 311 | TRF Vol: 1,395,393 | Short Ratio: 63.0% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
EVH Q1 2026 Earnings After Market Close — 2026-05-07
Apr 27, 2026
short_volume
Short Volume: EVH — 56.9% short (0.7M / 1.2M)
Short: 696,994 | Exempt: 4,635 | TRF Vol: 1,224,800 | Short Ratio: 56.9% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
short_volume
Short Volume: EVH — 55.5% short (1.2M / 2.2M)
Short: 1,237,359 | Exempt: 9,098 | TRF Vol: 2,229,100 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: EVH — 65.7% short (1.1M / 1.7M)
Short: 1,119,424 | Exempt: 0 | TRF Vol: 1,703,511 | Short Ratio: 65.7% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_volume
Short Volume: EVH — 67.8% short (1.6M / 2.4M)
Short: 1,600,528 | Exempt: 252,960 | TRF Vol: 2,362,040 | Short Ratio: 67.8% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_volume
Short Volume: EVH — 70.1% short (0.6M / 0.9M)
Short: 628,937 | Exempt: 32 | TRF Vol: 896,589 | Short Ratio: 70.1% | Off-exchange volume (dark pool + OTC)
Feb 24, 2026
earnings_calendar
EVH Q4 2025 Earnings After Market Close — 2026-02-24